Company Announcements

All company announcements are listed below. To receive them automatically, sign up to our email announcements.
15-Feb-18 Strategic Alliance and Capital Raising download
12-Feb-18 Update on Strategic Alliance download
6-Feb-18 Change of Chief Executive Officer download
5-Feb-18 Appendix 3x – Peter Rubinstein download
5-Feb-18 Appendix 3x – Samuel Lee download
5-Feb-18 Appendix 3x – Jerzy Muchnicki download
5-Feb-18 Appointment of Chairman download
2-Feb-18 Appendix 3z Eutillio Buccilli and Grahame Leonard download
31-Jan-18 Voluntary Suspension Request download
31-Jan-18 Results from 31 January 2018 General Meeting download
30-Jan-18 Resignation of Directors download
9-Jan-18 Genetic Technologies Regains Nasdaq Listing Compliance download
20-Dec-17 Notice of General Meeting and Sample Proxy download
12-Dec-17 Genetic Technologies Provides Update on Strategic Review Initiative download
4-Dec-17 Renaissance Technologies LLC – Notice of Initial Substantial Shareholding in Genetic Technologies Limited  download
1-Dec-17 Notice Received Under Section 249D of the Corporations Act  download
23-Nov-17 Results from 2017 Annual General Meeting download
23-Nov-17 Annual General Meeting Presentation 2017 download
23-Oct-17 Notice of 2017 Annual General Meeting and Sample Proxy download
21-Sept-2017 Genetic Technologies Transitions to Online Commercial Platform for
BREVAGenplus® download
29-Aug-2017 Appendix 4E & Financial Report 2017 download
29-Aug-2017 Appendix 4G and Corporate Governance Statement 2017 download
25-Aug -17 Genetic Technologies Announces Comprehensive Review of Strategic
Alternatives download
1-Aug -17 Genetic Technologies Launches Breast Cancer Awareness Month
Promotion for BREVAGenplus® download
21-July-17 Genetic Technologies Receives Nasdaq Deficiency Notice download
25-May-17 Appendix 3Y download
 31- March -17 Genetic Technologies Revamps Patient Pricing and Billing Program for BREVAGenplus® download
29- March -17 Genetic Technologies and IndyCar’s Pippa Mann Partner for Second Consecutive Year to Promote BREVAGenplus® download
20- Feb -17 Employee Share Options Issued and Forfeited download
6- Dec-16 Cleansing notice under section 708A the Corporations Act 2001 (Cthdownload
6-Dec-16 Capital Raising Update – Appendix 3B download
2-Dec-16 Genetic Technologies Announces AUD 8.1 million Capital Raising download
29-Nov-16 Exclusive License Agreement To Develop Colorectal Cancer Risk Assessment Test download
23-Nov-16 -16 2016 Annual General Meeting Results  download
23-Nov-16 -16 2016 Annual General Meeting Presentation download
24-Oct-16 Notice of 2016 Annual General Meeting and Sample Proxy download
3-Oct -16 Genetic Technologies Launches BREVAGenplus® Marketing Program
Around Susan G. Komen®’s Race for the Cure® Events download
30-Aug-2016 Appendix 4E & Financial Report 2016 download
30-Aug-2016 Appendix 4G and Corporate Governance Statement 2016 download
22 June -16 Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann Update BREVAGenplus® Marketing Partnership  download
21 June -16 Appointment of Senior Medical Director download
4-May -16 Genetic Technologies and Verizon IndyCar Series Driver Pippa Mann to
Ring Nasdaq Stock Market Closing Bell on May 6th, 2016 download
6-April -16 Appendix 3B download
6-April -16 Lapse of Share Options download
22-Feb -16 Genetic Technologies and IndyCar’s Pippa Mann Announce Partnership to
Promote BREVAGenplus® download
5-Feb -16 Settlement and Release Agreement with Hendrix Genetics B.V. download
13-Jan -16 Changes to Company Secretary download
21-Dec-15 Genetic Technologies Announces Publication of Key scientific Validation Results in Support of BREVAGenplus download
15-Dec-15 Appendix 3Y download
15-Dec-15 Appendix 3B download
25-Nov -15 Results from 2015 Annual General Meeting download
25-Nov -15 2015 Annual General Meeting download
23-Nov-15 Genetic Technologies Announces Publication Validating BREVAGenplus  Testing for African-American and Hispanic Women download
02-Nov-15 Appendix 3Y download
29-Oct-15 Appendix 4C download
27-Oct-15 Notice of AGM and Sample Proxy download
06-Oct -15 CFO Transition download
24-Sep-15 Appendix 4G and Corporate Governance Statement download
28-Aug-15 Lapse of Options download
06-Aug-15 US Patent Office Grants Key BREVAGENplus® download
31-July-15 Appendix 4C download
23-July-15 Appendix 3B download
14-July-15 Genetic Technologies Announces Scientific Validation, Clinical Trial and Peer Review Publication Initiatives download
09-July-15 Appointment of Joint Company Secretary download
15-June-15 Appointment of Chief Financial Officer download
12-June-15 Appointment of Executive Director download
29-May-15 Genetic Technologies supports research findings: Clinical validation is needed for gene-panel sequencing associated with hereditary breast cancer risk  download
04-May-15 Second of Two Nasdaq Deficiencies Successfully Remediated  download
23-April-15 Appendix 3Y  download
20-April-15 Additional Breast Health Centres To Begin Offering BREVAGENplus download
01-April-15 Appendix 3Y download

Subscribe to Company Announcements

Full name (required)


Email address (required)

Confirm email address (required)

Phone Number


Enquiry details